Analyze Diet
Frontiers in endocrinology2019; 10; 667; doi: 10.3389/fendo.2019.00667

The Interaction Between Nodal, Hypoxia-Inducible Factor 1 Alpha, and Thrombospondin 1 Promotes Luteolysis in Equine Corpus Luteum.

Abstract: The regulation of corpus luteus (CL) luteolysis is a complex process involving a myriad of factors. Previously, we have shown the involvement of Nodal in functional luteolysis in mares. Presently, we ask the extent of which Nodal mediation of luteolysis is done through regulation of angioregression. We demonstrated the interaction between Nodal and hypoxia-inducible factor 1 α (HIF1α) and thrombospondin 1/thrombospondin receptor (TSP1/CD36) systems, could mediate angioregression during luteolysis. First, we demonstrated the inhibitory effect of Nodal on the vascular marker platelet/endothelial cell adhesion molecule 1 (CD31). Also, treatment of mid CL explants with vascular endothelial growth factor A (VEGFA) showed a trend on activin-like kinase 7 (Alk7) protein inhibition. Next, Nodal was also shown to activate HIF1α and culture of mid CL explants under decreased oxygen level promoted Nodal expression and SMAD family member 3 (Smad3) phosphorylation. In another experiment, the crosstalk between Nodal and TSP1/CD36 was investigated. Indeed, Nodal increased the expression of the anti-angiogenic TSP1 and its receptor CD36 in mid CL explants. Finally, the supportive effect of prostaglandin F2α (PGF2α) on TSP1/CD36 was blocked by SB431542 (SB), a pharmacological inhibitor of Nodal signaling. Thus, we evidenced for the first time the interaction between Nodal and both HIF1α and TSP1 systems, two conserved pathways previously shown to be involved in vascular regression during luteolysis. Considering the given increased expression of Nodal in mid CL and its role on functional luteolysis, the current results suggest the additional involvement of Nodal in angioregression during luteolysis in the mare, particularly in the activation of HIF1α and TSP1/CD36.
Publication Date: 2019-10-01 PubMed ID: 31632347PubMed Central: PMC6779822DOI: 10.3389/fendo.2019.00667Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the role of the protein Nodal in the breakdown of the corpus luteum in horses, suggesting that Nodal likely influences this process indirectly through its interactions with two other biological systems, hypoxia-inducible factor 1 α (HIF1α) and thrombospondin 1/thrombospondin receptor (TSP1/CD36).

Introduction

  • The regulation of the degradation of corpus luteum, a structure integral to the menstrual cycle and pregnancy, is complex and involves many factors. This study builds on previous work demonstrating the role of the Nodal protein in this process.
  • The researchers aimed to discover the extent of Nodal’s role in angioregression – the regression of blood vessels – during luteolysis, the breakdown of the corpus luteum. They focused on the interactions between Nodal and two other biological systems, HIF1α and TSP1/CD36.

Methods and Results

  • The team used various experimental approaches to study the effects of Nodal on markers related to blood vessel formation. It was shown that Nodal inhibits the vascular marker CD31 and potentially decreases Alk7 protein when the corpus luteum is exposed to VEGFA, a major regulator of blood vessel formation.
  • They also determined Nodal’s effect on the activation of HIF1α, a key player in cellular responses to low oxygen conditions (hypoxia). When the corpus luteum was cultured in low-oxygen conditions, the expression of Nodal and the phosphorylation of Smad3, a protein involved in relaying Nodal signals, were increased.
  • The research further explored the interaction between Nodal and the TSP1/CD36 system, which is involved in inhibiting angiogenesis (formation of new blood vessels). Nodal was found to increase the expression of TSP1 and its receptor CD36.
  • Additionally, the study observed the effects of a pharmacological inhibitor of Nodal signalling, SB431542 (SB), which effectively blocked the influence of prostaglandin F2α (PGF2α), a hormone known to support TSP1/CD36.

Conclusion

  • This study provides evidence for the interaction of Nodal with both the HIF1α and TSP1 systems, which are involved in regulating blood vessel regression during luteolysis.
  • Given the increased expression of Nodal in mid corpus luteum and its previously demonstrated role in functional luteolysis, these results suggest an expanded role for Nodal in angioregression during luteolysis, particularly in the activation of HIF1α and TSP1/CD36.

Cite This Article

APA
Walewska E, Wołodko K, Skarzynski D, Ferreira-Dias G, Galvão A. (2019). The Interaction Between Nodal, Hypoxia-Inducible Factor 1 Alpha, and Thrombospondin 1 Promotes Luteolysis in Equine Corpus Luteum. Front Endocrinol (Lausanne), 10, 667. https://doi.org/10.3389/fendo.2019.00667

Publication

ISSN: 1664-2392
NlmUniqueID: 101555782
Country: Switzerland
Language: English
Volume: 10
Pages: 667
PII: 667

Researcher Affiliations

Walewska, Edyta
  • Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
Wołodko, Karolina
  • Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
Skarzynski, Dariusz
  • Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.
Ferreira-Dias, Graça
  • The Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon, Lisbon, Portugal.
Galvão, António
  • Department of Reproductive Immunology and Pathology, Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, Olsztyn, Poland.

References

This article includes 39 references
  1. Galvão AM, Ferreira-Dias G, Skarzynski DJ. Cytokines and angiogenesis in the corpus luteum.. Mediators Inflamm 2013;2013:420186.
    doi: 10.1155/2013/420186pmc: PMC3693155pubmed: 23840095google scholar: lookup
  2. Galvão A, Skarzynski D, Ferreira-Dias G. Nodal Promotes Functional Luteolysis via Down-Regulation of Progesterone and Prostaglandins E2 and Promotion of PGF2α Synthetic Pathways in Mare Corpus Luteum.. Endocrinology 2016 Feb;157(2):858-71.
    doi: 10.1210/en.2015-1362pubmed: 26653568google scholar: lookup
  3. Galvão A, Wolodko K, Rebordão MR, Skarzynski D, Ferreira-Dias G. TGFB1 modulates in vitro secretory activity and viability of equine luteal cells.. Cytokine 2018 Oct;110:316-327.
    doi: 10.1016/j.cyto.2018.03.038pubmed: 29627157google scholar: lookup
  4. Schier AF. Nodal signaling in vertebrate development.. Annu Rev Cell Dev Biol 2003;19:589-621.
  5. Ginther OJ, Gastal EL, Gastal MO, Utt MD, Beg MA. Luteal blood flow and progesterone production in mares.. Anim Reprod Sci 2007 May;99(1-2):213-20.
  6. Meidan R, Girsh E, Mamluk R, Farberov S. Chapter 9: Luteolysis in ruminants: past concepts, new insights, and persisting challenges. The Life Cycle of the Corpus Luteum Jerusalem: Springer Nture Inc; (2017). p. 159–83.
  7. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1.. J Biol Chem 1995 Jan 20;270(3):1230-7.
    doi: 10.1074/jbc.270.3.1230pubmed: 7836384google scholar: lookup
  8. Nishimura R, Sakumoto R, Tatsukawa Y, Acosta TJ, Okuda K. Oxygen concentration is an important factor for modulating progesterone synthesis in bovine corpus luteum.. Endocrinology 2006 Sep;147(9):4273-80.
    doi: 10.1210/en.2005-1611pubmed: 16740971google scholar: lookup
  9. Nishimura R, Komiyama J, Tasaki Y, Acosta TJ, Okuda K. Hypoxia promotes luteal cell death in bovine corpus luteum.. Biol Reprod 2008 Mar;78(3):529-36.
    doi: 10.1095/biolreprod.107.063370pubmed: 18046014google scholar: lookup
  10. Farberov S, Basavaraja R, Meidan R. Thrombospondin-1 at the crossroads of corpus luteum fate decisions.. Reproduction 2019 Mar;157(3):R73-R83.
    doi: 10.1530/REP-18-0530pubmed: 30566900google scholar: lookup
  11. Bornstein P. Thrombospondins function as regulators of angiogenesis.. J Cell Commun Signal 2009 Dec;3(3-4):189-200.
    doi: 10.1007/s12079-009-0060-8pmc: PMC2778581pubmed: 19798599google scholar: lookup
  12. Bornstein P. Thrombospondins as matricellular modulators of cell function.. J Clin Invest 2001 Apr;107(8):929-34.
    doi: 10.1172/JCI12749pmc: PMC199563pubmed: 11306593google scholar: lookup
  13. Berisha B, Schams D, Rodler D, Sinowatz F, Pfaffl MW. Expression and localization of members of the thrombospondin family during final follicle maturation and corpus luteum formation and function in the bovine ovary.. J Reprod Dev 2016 Oct 18;62(5):501-510.
    doi: 10.1262/jrd.2016-056pmc: PMC5081738pubmed: 27396384google scholar: lookup
  14. Jiménez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1.. Nat Med 2000 Jan;6(1):41-8.
    doi: 10.1038/71517pubmed: 10613822google scholar: lookup
  15. Galvao AM, Ramilo DW, Skarzynski DJ, Lukasik K, Tramontano A, Mollo A, Mateus LM, Ferreira-Dias GM. Is FAS/Fas ligand system involved in equine corpus luteum functional regression?. Biol Reprod 2010 Dec;83(6):901-8.
    doi: 10.1095/biolreprod.110.084699pubmed: 20720169google scholar: lookup
  16. Galvão A, Henriques S, Pestka D, Lukasik K, Skarzynski D, Mateus LM, Ferreira-Dias GM. Equine luteal function regulation may depend on the interaction between cytokines and vascular endothelial growth factor: an in vitro study.. Biol Reprod 2012 Jun;86(6):187.
    doi: 10.1095/biolreprod.111.097147pubmed: 22492973google scholar: lookup
  17. Koressaar T, Remm M. Enhancements and modifications of primer design program Primer3.. Bioinformatics 2007 May 15;23(10):1289-91.
    doi: 10.1093/bioinformatics/btm091pubmed: 17379693google scholar: lookup
  18. Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG. Primer3--new capabilities and interfaces.. Nucleic Acids Res 2012 Aug;40(15):e115.
    doi: 10.1093/nar/gks596pmc: PMC3424584pubmed: 22730293google scholar: lookup
  19. Zhao S, Fernald RD. Comprehensive algorithm for quantitative real-time polymerase chain reaction.. J Comput Biol 2005 Oct;12(8):1047-64.
    doi: 10.1089/cmb.2005.12.1047pmc: PMC2716216pubmed: 16241897google scholar: lookup
  20. Pepper MS. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity.. Cytokine Growth Factor Rev 1997 Mar;8(1):21-43.
    doi: 10.1016/S1359-6101(96)00048-2pubmed: 9174661google scholar: lookup
  21. Goumans MJ, Liu Z, ten Dijke P. TGF-beta signaling in vascular biology and dysfunction.. Cell Res 2009 Jan;19(1):116-27.
    doi: 10.1038/cr.2008.326pubmed: 19114994google scholar: lookup
  22. Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Wang J. TGF-Beta suppresses VEGFA-mediated angiogenesis in colon cancer metastasis.. PLoS One 2013;8(3):e59918.
  23. Wang Z, Han Z, Tao J, Wang J, Liu X, Zhou W, Xu Z, Zhao C, Ju X, Wang Z, Tan R, Gu M. Transforming Growth Factor-β1 Induces Endothelial-to-Mesenchymal Transition via Akt Signaling Pathway in Renal Transplant Recipients with Chronic Allograft Dysfunction.. Ann Transplant 2016 Dec 20;21:775-783.
    doi: 10.12659/AOT.899931pubmed: 27994216google scholar: lookup
  24. Maroni D, Davis JS. TGFB1 disrupts the angiogenic potential of microvascular endothelial cells of the corpus luteum.. J Cell Sci 2011 Jul 15;124(Pt 14):2501-10.
    doi: 10.1242/jcs.084558pmc: PMC6518331pubmed: 21693577google scholar: lookup
  25. Galvão AM, Skarzynski D, Ferreira-Dias G. Luteolysis and the Auto-, Paracrine Role of Cytokines From Tumor Necrosis Factor α and Transforming Growth Factor β Superfamilies.. Vitam Horm 2018;107:287-315.
    doi: 10.1016/bs.vh.2018.01.001pubmed: 29544635google scholar: lookup
  26. McCracken JA, Custer EE, Schreiber DT, Tsang PC, Keator CS, Arosh JA. A new in vivo model for luteolysis using systemic pulsatile infusions of PGF(2α).. Prostaglandins Other Lipid Mediat 2012 Mar;97(3-4):90-6.
  27. Miyamoto A, Shirasuna K, Wijayagunawardane MP, Watanabe S, Hayashi M, Yamamoto D, Matsui M, Acosta TJ. Blood flow: a key regulatory component of corpus luteum function in the cow.. Domest Anim Endocrinol 2005 Aug;29(2):329-39.
  28. Acosta TJ, Yoshizawa N, Ohtani M, Miyamoto A. Local changes in blood flow within the early and midcycle corpus luteum after prostaglandin F(2 alpha) injection in the cow.. Biol Reprod 2002 Mar;66(3):651-8.
    doi: 10.1095/biolreprod66.3.651pubmed: 11870071google scholar: lookup
  29. Mondal M, Schilling B, Folger J, Steibel JP, Buchnick H, Zalman Y, Ireland JJ, Meidan R, Smith GW. Deciphering the luteal transcriptome: potential mechanisms mediating stage-specific luteolytic response of the corpus luteum to prostaglandin F₂α.. Physiol Genomics 2011 Apr 27;43(8):447-56.
  30. Li H, Chen J, Wang X, He M, Zhang Z, Cen Y. Nodal induced by hypoxia exposure contributes to dacarbazine resistance and the maintenance of stemness in melanoma cancer stem‑like cells.. Oncol Rep 2018 Jun;39(6):2855-2864.
    doi: 10.3892/or.2018.6387pubmed: 29693169google scholar: lookup
  31. Quail DF, Taylor MJ, Walsh LA, Dieters-Castator D, Das P, Jewer M, Zhang G, Postovit LM. Low oxygen levels induce the expression of the embryonic morphogen Nodal.. Mol Biol Cell 2011 Dec;22(24):4809-21.
    doi: 10.1091/mbc.e11-03-0263pmc: PMC3237624pubmed: 22031289google scholar: lookup
  32. Lai JH, Jan HJ, Liu LW, Lee CC, Wang SG, Hueng DY, Cheng YY, Lee HM, Ma HI. Nodal regulates energy metabolism in glioma cells by inducing expression of hypoxia-inducible factor 1α.. Neuro Oncol 2013 Oct;15(10):1330-41.
    doi: 10.1093/neuonc/not086pmc: PMC3779039pubmed: 23911596google scholar: lookup
  33. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.. Mol Cell Biol 1996 Sep;16(9):4604-13.
    doi: 10.1128/MCB.16.9.4604pmc: PMC231459pubmed: 8756616google scholar: lookup
  34. Müller K, Ellenberger C, Schoon HA. Histomorphological and immunohistochemical study of angiogenesis and angiogenic factors in the ovary of the mare.. Res Vet Sci 2009 Dec;87(3):421-31.
    doi: 10.1016/j.rvsc.2009.04.011pubmed: 19447455google scholar: lookup
  35. Labrousse-Arias D, Castillo-González R, Rogers NM, Torres-Capelli M, Barreira B, Aragonés J, Cogolludo Á, Isenberg JS, Calzada MJ. HIF-2α-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction.. Cardiovasc Res 2016 Jan 1;109(1):115-30.
    doi: 10.1093/cvr/cvv243pmc: PMC4692290pubmed: 26503986google scholar: lookup
  36. Greenaway J, Gentry PA, Feige JJ, LaMarre J, Petrik JJ. Thrombospondin and vascular endothelial growth factor are cyclically expressed in an inverse pattern during bovine ovarian follicle development.. Biol Reprod 2005 May;72(5):1071-8.
    doi: 10.1095/biolreprod.104.031120pubmed: 15616224google scholar: lookup
  37. Zalman Y, Klipper E, Farberov S, Mondal M, Wee G, Folger JK, Smith GW, Meidan R. Regulation of angiogenesis-related prostaglandin f2alpha-induced genes in the bovine corpus luteum.. Biol Reprod 2012 Mar;86(3):92.
    doi: 10.1095/biolreprod.111.095067pubmed: 22174022google scholar: lookup
  38. Alessio M, De Monte L, Scirea A, Gruarin P, Tandon NN, Sitia R. Synthesis, processing, and intracellular transport of CD36 during monocytic differentiation.. J Biol Chem 1996 Jan 19;271(3):1770-5.
    doi: 10.1074/jbc.271.3.1770pubmed: 8576181google scholar: lookup
  39. Luiken JJ, Chanda D, Nabben M, Neumann D, Glatz JF. Post-translational modifications of CD36 (SR-B2): Implications for regulation of myocellular fatty acid uptake.. Biochim Biophys Acta 2016 Dec;1862(12):2253-2258.
    doi: 10.1016/j.bbadis.2016.09.004pubmed: 27615427google scholar: lookup

Citations

This article has been cited 1 times.
  1. Tang Z, Chen J, Zhang Z, Bi J, Xu R, Lin Q, Wang Z. HIF-1α Activation Promotes Luteolysis by Enhancing ROS Levels in the Corpus Luteum of Pseudopregnant Rats.. Oxid Med Cell Longev 2021;2021:1764929.
    doi: 10.1155/2021/1764929pubmed: 34512862google scholar: lookup